» Authors » Cruz Soriano

Cruz Soriano

Explore the profile of Cruz Soriano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 137
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aracil-Gisbert S, Fernandez-de-Bobadilla M, Guerra-Pinto N, Serrano-Calleja S, Perez-Cobas A, Soriano C, et al.
mBio . 2024 Apr; 15(5):e0305423. PMID: 38564701
is an opportunistic pathogen historically associated with sudden outbreaks in intensive care units (ICUs) and the spread of carbapenem-resistant genes. However, the ecology of populations in the hospital ecosystem remains...
2.
Fortun J, Gomez-Garcia de la Pedrosa E, Martinez-Lorca A, Paredes P, Martin-Davila P, Gomez-Lopez A, et al.
J Fungi (Basel) . 2024 Mar; 10(3). PMID: 38535200
Although nebulized liposomal amphotericin B (NLAB) is being used in invasive pulmonary aspergillosis (IPA) prophylaxis, no clinical trial has shown its efficacy as a therapeutic strategy. NAIFI is the inaugural...
3.
Peral J, Estella A, Nuvials X, Rodriguez A, Seijas I, Soriano C, et al.
J Fungi (Basel) . 2023 Mar; 9(3). PMID: 36983480
The aim of this study was to establish practical recommendations for the diagnosis and treatment of influenza-associated invasive aspergillosis (IAPA) based on the available evidence and experience acquired in the...
4.
Castillo-Polo J, Hernandez-Garcia M, Morosini M, Perez-Viso B, Soriano C, de Pablo R, et al.
J Antimicrob Chemother . 2023 Mar; 78(5):1259-1264. PMID: 36964710
Objectives: Ceftazidime/avibactam and cefiderocol are two of the latest antibiotics with activity against a wide variety of Gram-negatives, including carbapenem-resistant Enterobacterales. We sought to describe the phenotypic and genotypic characteristics...
5.
Fortun J, Mateos M, Gomez-Garcia de la Pedrosa E, Soriano C, Pestana D, Palacios J, et al.
J Fungi (Basel) . 2023 Feb; 9(2). PMID: 36836245
The recent European Confederation of Medical Mycology (ECMM) and the International Society for Human and Animal Mycology (ISHAM) 2020 consensus classification proposes criteria to define coronavirus 2019 (COVID-19)-associated invasive pulmonary...
6.
Vidal-Cortes P, Martin-Loeches I, Rodriguez A, Bou G, Canton R, Diaz E, et al.
Antibiotics (Basel) . 2022 Sep; 11(9). PMID: 36139940
Infections due to have been increasing in intensive care units (ICUs) in the last decade. Such infections pose a serious problem, especially when antimicrobial resistance is present. We created a...
7.
Martin M, Vallejo C, Lopez-Campos F, Quereda C, Munoz T, Sanchez-Conde M, et al.
Oncology . 2022 Sep; 101(1):1-11. PMID: 36063800
Introduction: Cancer patients are more susceptible to infections, and infection can be more severe than in patients without cancer diagnosis. We conducted this retrospective study in patients admitted for SARS-CoV-2...
8.
Zaragoza R, Vidal-Cortes P, Aguilar G, Borges M, Diaz E, Ferrer R, et al.
Crit Care . 2020 Jul; 24(1):383. PMID: 32600375
In accordance with the recommendations of, amongst others, the Surviving Sepsis Campaign and the recently published European treatment guidelines for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), in the event...
9.
Jose P, Alvarez-Lerma F, Maseda E, Olaechea P, Peman J, Soriano C, et al.
J Chemother . 2019 Feb; 31(2):64-73. PMID: 30761948
A narrative review from a multidisciplinary task force of experts in critical care medicine and clinical mycology was carried out. The multi drug-resistant species Candida auris has emerged simultaneously on...
10.
Valles J, Martin-Loeches I, Torres A, Diaz E, Seijas I, Lopez M, et al.
Intensive Care Med . 2014 Mar; 40(4):572-81. PMID: 24638939
Purpose: Information about healthcare-associated pneumonia (HCAP) in critically ill patients is scarce. Methods: This prospective study compared clinical presentation, outcomes, microbial etiology, and treatment of HCAP, community-acquired pneumonia (CAP), and...